These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32485087)

  • 1. Hyperforin induces apoptosis through extrinsic/intrinsic pathways and inhibits EGFR/ERK/NF-κB-mediated anti-apoptotic potential in glioblastoma.
    Hsu FT; Chen WT; Wu CT; Chung JG
    Environ Toxicol; 2020 Oct; 35(10):1058-1069. PubMed ID: 32485087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
    Zhou C; Tabb MM; Sadatrafiei A; Grün F; Sun A; Blumberg B
    J Clin Immunol; 2004 Nov; 24(6):623-36. PubMed ID: 15622447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperforin Inhibits Cell Growth by Inducing Intrinsic and Extrinsic Apoptotic Pathways in Hepatocellular Carcinoma Cells.
    Chiang IT; Chen WT; Tseng CW; Chen YC; Kuo YC; Chen BJ; Weng MC; Lin HJ; Wang WS
    Anticancer Res; 2017 Jan; 37(1):161-167. PubMed ID: 28011486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperforin Induces Apoptosis Through Extrinsic/Intrinsic Pathways and Inhibits NF-ĸB-modulated Survival and Invasion Potential in Bladder Cancer.
    Liu YC; Lin KH; Hsieh JH; Chung JG; Tan ZL; Hsu FT; Chiang CH
    In Vivo; 2019; 33(6):1865-1877. PubMed ID: 31662514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperforin Suppresses Tumor Growth and NF-κB-mediated Anti-apoptotic and Invasive Potential of Non-small Cell Lung Cancer.
    Chen WT; Chen YK; Lin SS; Hsu FT
    Anticancer Res; 2018 Apr; 38(4):2161-2167. PubMed ID: 29599335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line.
    Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P
    Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. St. John's wort extract and hyperforin inhibit multiple phosphorylation steps of cytokine signaling and prevent inflammatory and apoptotic gene induction in pancreatic β cells.
    Novelli M; Menegazzi M; Beffy P; Porozov S; Gregorelli A; Giacopelli D; De Tata V; Masiello P
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):92-104. PubMed ID: 27780755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic insights into the antileukemic activity of hyperforin.
    Billard C; Merhi F; Bauvois B
    Curr Cancer Drug Targets; 2013 Jan; 13(1):1-10. PubMed ID: 22924417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of β1 -adrenergic receptors in rat C6 glioblastoma cells by hyperforin and hyperoside from St John's wort.
    Jakobs D; Hage-Hülsmann A; Prenner L; Kolb C; Weiser D; Häberlein H
    J Pharm Pharmacol; 2013 Jun; 65(6):907-15. PubMed ID: 23647684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-κB signalling participate in anti-glioblastoma of imipramine.
    Hsu FT; Chiang IT; Wang WS
    J Cell Mol Med; 2020 Apr; 24(7):3982-4000. PubMed ID: 32149465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
    J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperforin: more than an antidepressant bioactive compound?
    Medina MA; Martínez-Poveda B; Amores-Sánchez MI; Quesada AR
    Life Sci; 2006 Jun; 79(2):105-11. PubMed ID: 16438991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
    Bouron A; Lorrain E
    Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro.
    Hostanska K; Reichling J; Bommer S; Weber M; Saller R
    Pharmazie; 2002 May; 57(5):323-31. PubMed ID: 12061257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process.
    Martínez-Poveda B; Quesada AR; Medina MA
    Int J Cancer; 2005 Dec; 117(5):775-80. PubMed ID: 15981212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperforin is a modulator of inducible nitric oxide synthase and phagocytosis in microglia and macrophages.
    Kraus B; Wolff H; Elstner EF; Heilmann J
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):541-53. PubMed ID: 20369228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis induction and ERK/NF-κB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo.
    Tsai JJ; Chen JH; Chen CH; Chung JG; Hsu FT
    Environ Toxicol; 2020 Feb; 35(2):167-175. PubMed ID: 31714653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of STAT-1 inhibition and induction of cytokine resistance in pancreatic β cells treated with St John's wort and its component hyperforin.
    Novelli M; Beffy P; Gregorelli A; Porozov S; Mascia F; Vantaggiato C; Masiello P; Menegazzi M
    J Pharm Pharmacol; 2019 Jan; 71(1):93-103. PubMed ID: 28990659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis.
    Schempp CM; Kirkin V; Simon-Haarhaus B; Kersten A; Kiss J; Termeer CC; Gilb B; Kaufmann T; Borner C; Sleeman JP; Simon JC
    Oncogene; 2002 Feb; 21(8):1242-50. PubMed ID: 11850844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of high-affinity beta2-adrenergic receptor binding by hyperforin and hyperoside on rat C6 glioblastoma cells measured by fluorescence correlation spectroscopy.
    Prenner L; Sieben A; Zeller K; Weiser D; Häberlein H
    Biochemistry; 2007 May; 46(17):5106-13. PubMed ID: 17417877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.